Category Archives: Health Care

Five Star Alters Strategy, Its Stock Gets Slammed

In early April, Five Star announced a change in its strategy whereby it will transition out of the management of 108 smaller senior living communities (SLCs) with 7,500 living units (with an average of 69.4 units per community), close and … Continue reading

Posted in DHC, FVE, Health Care | Tagged , | Comments Off on Five Star Alters Strategy, Its Stock Gets Slammed

Assessing the Impact of the Organon Spin-Off on Merck

Merck is progressing toward the spin-off of its subsidiary, Organon & Co., which is expected to be completed by the end of the June.  Organon will include Merck’s women’s health products, biosimilars and certain established brands, most of which have … Continue reading

Posted in Health Care, MRK, OGN | Tagged , , , | Comments Off on Assessing the Impact of the Organon Spin-Off on Merck

Five Star and DHC Restructure Their Agreement

On April 9, Five Star and DHC announced a restructuring of their management agreement whereby DHC will transition the management of 108 smaller senior living communities (SLCs) with a total of 7,500 units to other operators by the end of … Continue reading

Posted in DHC, FVE, Health Care, Real Estate | Tagged , | Comments Off on Five Star and DHC Restructure Their Agreement

Merck Spin-Off of Organon Targeted for 21Q2

In recent weeks, Merck has been following through on its plan to spin-off its subsidiary, Organon & Co., to shareholders.  On March 17, it filed its Form 10 registration statement related to the transaction.  On March 24, it posted on … Continue reading

Posted in Health Care, MRK, OGN | Tagged , , | Comments Off on Merck Spin-Off of Organon Targeted for 21Q2

Citius Pharma Raises $71 million in Equity Unit Offering

Citius Pharmaceuticals (CXTR) is a specialty pharmaceutical company focused on the development of four potential products: (1) Mino-Lok, an antibiotic lock solution to treat and salvage infected central venous catheters (“CVCs”) in patients with catheter-related bloodstream infections (“CRBSIs”); Halo-Lido, a … Continue reading

Posted in CTXR, Health Care | Tagged , | Comments Off on Citius Pharma Raises $71 million in Equity Unit Offering

Five Star Senior Living (FVE) Update

Vaccination of 90% of Residents Raises Visibility on a Rebound in Occupancy Five Star reported slightly stronger 20Q4 results than anticipated, due primarily to gains on investments held by its captive insurer.  Average occupancy across its owned and leased senior … Continue reading

Posted in DHC, FVE, Health Care, Real Estate | Tagged , | Comments Off on Five Star Senior Living (FVE) Update

2021 Market Outlook – Part 2: S&P 500 Sector Analysis

2020 was of course dominated by the impact of the pandemic on the economy and specifically on the revenues and profits of each of the S&P 500 constituents.  There was a sharp stock market sell-off in March-April, followed by a … Continue reading

Posted in Communication Services, Consumer Discretionary, Consumer Staples, Energy, Financials, Health Care, Housing, Industrials, Market Commentary, Materials, Real Estate, Sectors, Technology, Telecommunications, Utilities | Tagged | Comments Off on 2021 Market Outlook – Part 2: S&P 500 Sector Analysis

Five Star’s Strong Stock Performance Could Signal Quicker Turnaround

Five Star Senior Living continues to cope with the effects of the COVID-19 pandemic on its operations.  During the 2020 second quarter, it experienced a 3.8% decline in occupancy from 82.5% to 78.7% across its owned and managed senior living … Continue reading

Posted in DHC, FVE, Health Care | Tagged , | Comments Off on Five Star’s Strong Stock Performance Could Signal Quicker Turnaround

After Completing Its Corporate Transition, Change Healthcare Copes With COVID-19

Change Healthcare Inc. (CHNG, Change Inc., Change or Inc.) is a new public company formed in 2016 as a joint venture between McKesson Corporation (MCK) and an investor group led by The Blackstone Group.  Over the past four years, the … Continue reading

Posted in CHNG, Health Care, Technology | Tagged , , | Comments Off on After Completing Its Corporate Transition, Change Healthcare Copes With COVID-19

Notes and Analysis from Merck’s Investor Day

On June 20, Merck held an investor day, its first in five years, to highlight its goals and objectives and provide a broad perspective on its five-year performance outlook.  Although its blockbuster cancer treatment, KEYTRUDA (pembrolizumab), has been a spectacular … Continue reading

Posted in Health Care, MRK | Tagged , | Comments Off on Notes and Analysis from Merck’s Investor Day